Commonwealth Equity Services
MRNS

Commonwealth Equity Services’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Commonwealth Equity Services’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,518
Closed -$7K – 4324
2024
Q4 		$7K Sell
12,518
-100
-0.8% -$70 ﹤0.01% 4081
2024
Q3 		$22K Buy
12,618
+985
+8% +$1.38K ﹤0.01% 3991
2024
Q2 		$14K Buy
+11,633
New +$29.1K ﹤0.01% 3985

Commonwealth Equity Services's MRNS Position: Q1 2025 in Review

Commonwealth Equity Services sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 12,518 shares — an estimated $7K sold.

Commonwealth Equity Services first reported a position in MRNS in Q2 2024 and held it in 3 quarters. The position peaked at $22K in Q3 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

  • Commonwealth Equity Services reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 12,518 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $7K.
  • Commonwealth Equity Services first reported a position in Marinus Pharmaceuticals, Inc in Q2 2024 and held it in 3 quarters.
  • Commonwealth Equity Services's Marinus Pharmaceuticals, Inc position peaked at $22K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Commonwealth Equity Services's 13F filing for Q1 2025, filed 9 May 2025.